3′3′-cyclic dinucleotides
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F22%3A00559917" target="_blank" >RIV/61388963:_____/22:00559917 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/066440087/publication/US11292812B2?q=US11292812" target="_blank" >https://worldwide.espacenet.com/patent/search/family/066440087/publication/US11292812B2?q=US11292812</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
3′3′-cyclic dinucleotides
Original language description
The present invention relates to 3′3′-cyclic dinucleotides modified with a 3′-phosphonoalkyl bond and derivatives thereof, that can modulate the activity of the STING adaptor protein.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
<a href="/en/project/EF16_019%2F0000729" target="_blank" >EF16_019/0000729: Chemical biology for drugging undruggable targets</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
US11292812
Publisher
US001 -
Publisher name
United States Patent and Trademark Office (USPTO)
Place of publication
Alexandria
Publication country
US - UNITED STATES
Date of acceptance
Apr 5, 2022
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence